GATA2 deficiency

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 1, 2015, Pages 104-109

  Hsu, Amy P ^a   McReynolds, Lisa J ^a,b   Holland, Steven M ^a  

^a National Institute of Allergy and Infectious Diseases   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

GATA2; haploinsufficiency; lymphedema; myelodysplastic syndrome; nontuberculous mycobacteria; pulmonary alveolar proteinosis

Indexed keywords

AZITHROMYCIN; CYCLOPHOSPHAMIDE; FLT3 LIGAND; TRANSCRIPTION FACTOR GATA 2; GATA2 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; APLASTIC ANEMIA; BACTERIAL INFECTION; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CHRONIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOGENETICS; CYTOPENIA; DISEASE COURSE; EXON; GENE MUTATION; GERMLINE MUTATION; HAPLOINSUFFICIENCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HETEROZYGOTE; HUMAN; LONG TERM CARE; LUNG ALVEOLUS PROTEINOSIS; LUNG FUNCTION; LYMPHEDEMA; MOLECULAR GENETICS; MONOSOMY 7; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHODGKIN LYMPHOMA; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REFRACTORY ANEMIA WITH EXCESS BLASTS; REVIEW; RISK FACTOR; RNA SEQUENCE; SOMATIC MUTATION; ANIMAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEMATOLOGIC NEOPLASMS; INFECTION; MUTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; GATA2 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HUMANS; INFECTION; MUTATION; POLYMORPHISM, GENETIC;

EID: 84920869284     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000126     Document Type: Review

References (48)

1. Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic mono-cytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 2010; 115:1519-1529.
2. Bigley V, Collin M. Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome. Haematologica 2011; 96:1081-1083.
3. Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 2011; 118:2653-2655.
4. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 2011; 118:2656-2658.
5. Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011; 43:1012-1017.
6. Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 2011; 43:929-931.
7. Horwitz MS. GATA2 deficiency: flesh and blood. Blood 2014; 123:799-800.
8. West AH, Godley LA, Churpek JE. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations. Ann NY Acad Sci 2014; 1310:111-118.
9. Pasquet M, Bellanné-Chantelot C, Tavitian S, et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMacsyndrome, myelodysplasia, and acute myeloid leukemia. Blood 2013; 121:822-829.
10. Wozniak RJ, Boyer ME, Grass JA, et al. Context-dependent GATA factor function: combinatorial requirements for transcriptional control in hemato-poietic and endothelial cells. J Biol Chem 2007; 282:14665-14674.
11. Johnson KD, Hsu AP, Ryu MJ, et al. Cis-element mutated in GATA2-depen-dent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest 2012; 122:3692-3704.
12. Lim KC, Hosoya T, Brandt W, et al. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest 2012; 122:3705-3717.
13. Hsu AP, Johnson KD, Falcone EL, et al. GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 2013; 121:3830.S1-3837.S7.
14. Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 2014; 123:809-821.
15. Seidman JG, Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough. J Clin Invest 2002; 109:451-455.
16. Townsely DM, Hsu A, Dumitriu B, et al. Regulatory mutations in GATA2 associated with aplastic anemia. Blood (ASH Annual Meeting Abstracts) 2012; 120:3488.
17. Badhai J, Schuster J, Gidlöf O, Dahl N. 5'UTR variants of ribosomal protein S19 transcript determine translational efficiency: implications for Diamond-Blackfan anemia and tissue variability. PLoS One 2011; 6:e17672.
18. Hofmann I, Kierstead D, Krasker J, et al. Blood (ASH Annual Meeting Abstracts) 2013 122:1520.
19. Hsu A, Gramatges MM, Williams C, et al. GATA2 mutations in nonsyndromic pediatric myelodysplastic syndrome. Blood (ASH Annual Meeting Abstracts) 2013; 122:2778.
20. Mutsaers PG, van de Loosdrecht AA, Tawana K, et al. Highly variable clinical manifestations in a large family with a novel GATA2 mutation. Leukemia 2013; 27:2247-2248.
21. Dickinson RE, Milne P, Jardine L, et al. The evolution of cellular deficiency in GATA2 mutation. Blood 2014; 123:863-874.
22. Wodnar-Filipowicz A, Lyman SD, Gratwohl A, et al. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 1996; 88:4493-4499.
23. Sproull M, Avondoglio D, Kramp T, et al. Correlation of plasma FL expression with bone marrow irradiation dose. PLoS One 2013; 8:e58558.
24. Ganapathi KA, Townsley DM, Hsu AP, et al. Bone marrow morphologic and flow cytometric features assist in differentiating GATA2 mutation associated-hypocellular MDS from aplastic anemia. Modern Pathol 2014; 27:332-390.
25. Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371:221-226.
26. de Pater E, Kaimakis P, Vink CS, et al. Gata2 is required for HSC generation and survival. J Exp Med 2013; 210:2843-2850.
27. Ling KW, Ottersbach K, van Hamburg JP, et al. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med 2004; 200:871-882.
28. Rodrigues NP, Janzen V, Forkert R, et al. Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 2005; 106:477-484.
29. Rodrigues NP, Boyd AS, Fugazza C, et al. GATA-2 regulates granulocyte macrophage progenitor cell function. Blood 2008; 112:4862-4873.
30. Bresnick EH, Katsumura KR, Lee HY, et al. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res 2012; 40:5819-5831.
31. Vicente C, Conchillo A, Garćia-Sánchez MA, et al. The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit Rev Oncol Hematol 2012; 82:1-17.
32. Wilson NK, Foster SD, Wang X, et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcrip-tional regulators. Cell Stem Cell 2010; 7:532-544.
33. Beck D, Thoms JA, Perera D, et al. Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood 2013; 122:e12-22.
34. Starczynowski DT, Kuchenbauer F, Wegrzyn J, et al. MicroRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol 2011; 39:167-178; e4.
35. So AY, Zhao JL, Baltimore D. The Yin and Yang of microRNAs: leukemia and immunity. Immunol Rev 2013; 253:129-145.
36. Zhao JL, Rao DS, Boldin MP, et al. NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci USA 2011; 108:9184-9189.
37. Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 2012; 119:1283-1291.
38. Calvo KR, Vinh DC, Maric I, et al. Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications. Haematologica 2011; 96:1221-1225.
39. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed Lyon, France: International Agency for Research on Cancer (IARC); 2008.
40. West RR, Hsu AP, Holland SM, et al. Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica 2014; 99:276-281.
41. Thol F, Friesen I, Damm F, et al. Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol 2011; 29:2499-2506.
42. Bödör C, Renneville A, Smith M, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica 2012; 97:890-894.
43. Celton M, Forest A, Gosse G, et al. Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia. Leukemia 2014; 28:1617-1626.
44. Shiba N, Funato M, Ohki K, et al. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia. Br J Haematol 2014; 164:142-145.
45. Gröschel S, Sanders MA, Hoogenboezem R, et al. A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 2014; 157:369-381.
46. Yamazaki H, Suzuki M, Otsuki A, et al. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell 2014; 25:415-427.
47. Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 2011; 118:3715-3720.
48. Grossman J, Cuellar-Rodriguez J, Geo-Banacloche J, et al. Reduced intensity allogeneic hematopoietic stem-cell transplantation for GATA2 deficiency. Biol Blood Marrow Transplant 2014. [Epub ahead of print]